NeuroOne Medical Technologies Corporation
NMTCNeuroOne Medical Technologies Corporation is a medical technology company specializing in thin-film electrode technology for the diagnosis and treatment of neurological disorders.
Earnings
Next report
Aug 13, 2026 (Tomorrow)Competitors
By market cap
By revenue growth
Profile
NeuroOne Medical Technologies Corporation is a medical technology company specializing in thin-film electrode technology for the diagnosis and treatment of neurological disorders. The company develops minimally invasive 'all-in-one' solutions for recording, monitoring, and stimulating brain activity, as well as radiofrequency ablation for conditions like epilepsy, Parkinson's disease, and chronic pain.
NeuroOne is an emerging player in the neurotechnology space, leveraging a strategic global distribution partnership with Zimmer Biomet to compete against established medical device giants.
FAQ
- What is NeuroOne Medical Technologies Corporation's market cap?
- NeuroOne Medical Technologies Corporation (NMTC) has a market capitalization of $13.6M and trades on NASDAQ.
- Who are NeuroOne Medical Technologies Corporation's competitors?
- NeuroOne Medical Technologies Corporation's key competitors include ClearPoint Neuro, Inc., Medtronic plc, Stryker Corporation, and others. These companies compete in similar markets and product categories.
- Who does NeuroOne Medical Technologies Corporation partner with?
- NeuroOne Medical Technologies Corporation's notable partners include Zimmer Biomet Holdings, Inc., Wisconsin Alumni Research Foundation, Mayo Foundation for Medical Education and Research, and others.
- What subsidiaries does NeuroOne Medical Technologies Corporation have?
- NeuroOne Medical Technologies Corporation's subsidiaries include NeuroOne, Inc..
- Where is NeuroOne Medical Technologies Corporation headquartered?
- NeuroOne Medical Technologies Corporation is headquartered in United States of America and employs approximately 16 people. It has been publicly traded since 2012.